Human platelets produce granulocyte-macrophage colony-stimulating factor and delay eosinophil apoptosis

Laboratory Investigation

Volumn 83, Issue 4, 2003, Pages 589-598

  Raiden, Silvina ^a   Schettini, Jorge ^a   Salamone, Gabriela ^a   Trevani, Analía ^a   Vermeulen, Mónica ^a   Gamberale, Romina ^a,b   Giordano, Mirta ^a,b   Geffner, Jorge R ^a,b,c  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; CYTOKINE; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NEUTRALIZING ANTIBODY; PRONASE;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONCENTRATION (PARAMETERS); EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SUPERNATANT; THROMBOCYTE;

EID: 0037392703     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000062851.71286.47     Document Type: Article

References (56)

1. Alam R, Forsythe P, Stafford S, and Fukuda Y (1994). Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med 179:1041-1045.
2. Andonegui G, Trevani A, Lopez D, Raiden S, Giordano M, and Geffner J (1997). Inhibition of human neutrophil apoptosis by platelets. J Immunol 158:3372-3377.
3. Blaylock MG, Sexton DW, and Walsh GM (1999). Ligation of CD45 and the isoforms CD45RA and CD45RB accelerates the rate of constitutive apoptosis in human eosinophils. J Allergy Clin Immunol 104:1244-1250.
4. Boyum A (1968). Separation of leukocytes from blood and bone marrow. J Lab Invest 22(Suppl 97):77-85.
5. Burgers JA, Schweizer RC, Koenderman L, Bruijnzeel PLB, and Akkerman JWN (1993). Human platelets secrete chemotactic activity for eosinophils. Blood 81:49-55.
6. Chihara J and Nakajima S (1989). Platelet factor 4 has chemotactic activity for eosinophils and augments Fc gamma and Fcγ receptor expression on eosinophils. In: Morley J and Colditz I, editors. Perspectives in asthma. Eosinophils in asthma. London: Academic Press, 151-159.
7. Coligan JE (1994). Morphological and biochemical assays of apoptosis. In: Coligan JE, Kruibeek AM, Margulies AH, Shevach EM, and Strober W, editors. Current protocols in immunology. New York: John Wiley & Sons, 3.17-3.22.
8. Costa JJ, Weller PF, and Galli SJ (1997). The cells of the allergic response. JAMA 278:1815-1822.
9. Coyle AJ, Page CP, Atkinson L, Flanagan R, and Metzger WJ (1990). The requirement for platelets in allergen-induced late asthmatic airway obstruction. Eosinophil infiltration and heightened airway responsiveness in allergic rabbits. Am Rev Respir Dis 142:587-593.
10. Daigle I, Yousefi S, Colonna M, Green DR, and Simon HU (2002). Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat Med 8:61-67.
11. Deuel TF, Señor RM, Huang JS, and Griffin GL (1982). Chemotaxis of monocytes and neutrophils to platelet derived growth factor. J Clin Invest 69:1046-1049.
12. Dombrowicz D and Capron M (2001). Eosinophils, allergy and parasites. Curr Opin Immunol 13:16-20.
13. Esnault S and Malter JS (2001). Granulocyte macrophage-colony-stimulating factor mRNA is stabilized in airway eosinophils and peripheral blood eosinophils activated by TNF-alpha plus fibronectin. J Immunol 166:4658-4663.
14. Gleich GJ (1990). The eosinophil and bronchial asthma: Current understanding. J Allergy Clin Immunol 85:422-436.
15. Gleich GJ (2000). Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105:651-663.
16. Grainger DJ, Mosedale DE, Metcalfe JC, Weissberg PL, and Kemp PR (1995). Active and acid-activatable TGF-beta in human sera, platelets and plasma. Clin Chim Acta 235:11-31.
17. Haslett C (1999). Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 160(5 Pt 2):S5-S11.
18. Hawrylowicz CM, Santoro SA, Platt FM, and Unanue ER (1989). Activated platelets express IL-1 activity. J Immunol 43:4015-4018.
19. Homburg CHE, De Haas M, von dem Borne AEG, Verhoeven AJ, Reutelingsperger CPM, and Roos D (1995). Human neutrophils lose their surface Fcγ R and acquire annexin V binding sites during apoptosis in vitro. Blood 85:532-540.
20. Jian S, Levine JD, Fu Y, Deng B, London R, Groopman JE, and Avraham H (1994). Cytokine production by bone marrow megakaryocytes. Blood 84:4151-4156.
21. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, and Schroder JM (1992). Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 176:587-592.
22. Kao JPY, Harootunian AT, and Tsien RY (1989). Photochemically generated cytosolic calcium pulses and their detection by fluo-3. J Biol Chem 264:8179-8184.
23. Knauer KA, Lichtenstein LM, Adkinson NF, and Fish JE (1981). Platelet activation during antigen-induced airway reactions in asthmatic subjects. N Engl J Med 304:1404-1407.
24. Lellouch-Tubiana A, Lefort J, Simon MT, Pfister A, and Vargaftig BB (1988). Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. Am Rev Respir Dis 137:948-954.
25. Levi-Schaffer FL, Temkin V, Malamud V, Feld S, and Zilberman Y (1998). Mast cells enhance eosinophil survival in vitro: Role of TNF-α and granulocyte-macrophage colony-stimulating factor. J Immunol 160:5554-5562.
26. Lopez AF, Williamson DJ, Gamble JR, Begley CG, Harlan JM, Klebanoff SJ, Waltersdorph A, Wong G, Clark SC, and Vadas MA (1986). Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro human mature neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 78:1220-1228.
27. Luttman W, Knoechel B, Foerster M, Matthys H, Virchow JC, and Kroegel C (1996). Activation of human eosinophils by IL-13. J Immunol 157:1678-1683.
28. McCrae KR, Shattil SJ, and Cines DB (1990). Platelet activation induced increased Fc receptor expression. J Immunol 144:3920-3297.
29. McEver RP (1994). Selectins. Curr Opin Immunol 6:75-84.
30. Moqbel R, Hamid Q, Ying S, Barkans J, Hartnell A, Tsicopoulos A, Wardlaw AJ, and Kay AB (1991). Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med 174:749-752.
31. Morley J, Sanjar S, and Page CP (1985). The platelet in asthma. Lancet 2:726-727.
32. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, and Ricciardi C (1991). A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279.
33. Nimer SD and Uchida H (1995). Regulation of granulocyte-macrophage colony-stimulating factor and interleukin 3 expression. Stem Cells 13:324-335.
34. Nimer S, Zhang J, Avraham H, and Miyazaki Y (1996). Transcriptional regulation of interleukin-3 expression in megakaryocytes. Blood 88:66-74.
35. Nutku E, Zhuang Q, Soussi-Gounni A, Aris F, Mazer BD, and Hamid Q (2001). Functional expression of IL-12 receptor by human eosinophils: IL-12 promotes eosinophil apoptosis. J Immunol 167:1039-1046.
36. Okada S, Hagan JB, Kato M, Bankers-Fulbright JL, Hunt LW, Gleich GJ, and Kita H (1998). Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils. J Immunol 160:4010-4017.
37. Page CP (1988). The involvement of platelets in nonthrombotic processes. Trends Pharmacol Sci 9:66-71.
38. Page CP and Coyle AJ (1989). The interaction between PAF, platelets and eosinophils in bronchial asthma. Eur Respir J Suppl 6:483-487.
39. Perssen CGA and Erjefalt JS (1997). Ultimate activation of eosinophils in vivo: Lysis and release of clusters of free eosinophil granules. Thorax 52:569-574.
40. Platt N, da Silva RP, and Gordon S (1998). Recognizing death: The phagocytosis of apoptotic cells. Trends Cell Biol 3:356-372.
41. Rothenberg ME, Owen WF, and Silberstein DS (1988). Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin-3. J Clin Invest 81:1986-1992.
42. Salamone G, Giordano M, Trevani A, Gamberale R, Vermeulen M, and Geffner J (2001). Promotion of neutrophil apoptosis by TNF-α. J Immunol 166:3476-3482.
43. Shao-Bo S, Mukaida N, and Matsushima K (1996). Rapid secretion of intracellularly pre-stored interleukin-8 from rabbit platelets upon activation. J Leuk Biol 59:420-426.
44. Simon HU and Blazer K (1995). Inhibition of programmed eosinophil death: A key pathogenic event for eosinophilia? Immunol Today 16:53-55.
45. Stern M, Savill J, and Haslett C (1996). Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis: Mediation by α v β3/CD36/ thrombospondin recognition mechanism and lack of phlogistic response. Am J Pathol 149:911-921.
46. Tai PC, Sun L, and Spry CJ (1991). Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol 85:312-316.
47. Trevani A, Andonegui G, Giordano M, Nosari M, Fontán P, and Geffner JR (1996). Neutrophil apoptosis induced by proteolytic enzymes. Lab Invest 74:711-721.
48. Wallen N, Kita H, Weiler D, and Gleich J (1991). Glucocorticolds inhibit cytokine mediated eosinophil survival. J Immunol 147:3490-3495.
49. Walsh GM (2000). Eosinophil apoptosis: Mechanisms and clinical relevance in asthmatic and allergic inflammation. Br J Haematol 111:61-67.
50. Walsh GM, Sexton DW, Blaylock MG, and Convery CM (1999). Resting and cytokine-stimulated human small airway epithelial cells recognize and ingest apoptotic eosinophils. Blood 94:2827-2835.
51. Walsh GM, Williamson ML, Symon FA, Willars GB, and Wardlaw AJ (1996). Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor. Blood 87:2815-2821.
52. Wardlaw AJ, Moqbel R, Cromwell O, and Kay AB (1986). Platelet activating factor: A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 78:1701-1706.
53. Weidi B, Raap U, Lewrick H, and Kapp A (1998). IL-4-induced apoptosis in peripheral blood eosinophils. J Allergy Clin Immunol 102:1013-1020.
54. Wickenhauser C, Lorenzen J, Thiele J, Hillienhof A, Jungheim K, Schmitz B, Hansmann ML, and Fischer R (1995). Secretion of cytokines (interleukins-1 alpha, -3, and -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes. Blood 85:685-691.
55. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, and Kasahara T (1991). Analysis of the survival of mature human eosinophils: Interleukin-5 prevents apoptosis in mature human eosinophils. Blood 78:2542-2547.
56. Yasuba H, Chihara J, Kino T, Satake N, and Oshima S (1991). Increased releasability of platelet products and reduced heparin-induced platelet factor 4 release from endothelial cells in bronchial asthma. J Lipid Mediat 4:5-21.